Monocyte function rather than number is a prerequisite for the stimulation of collateral growth

Atherosclerosis

Volumn 196, Issue 1, 2008, Pages 485-486

  Czepluch, Frauke S ^a   Waltenberger, Johannes ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Arteriogenesis; Biomarker; Cardiovascular risk factor; Chemotaxis; Collateral; Monocyte

Indexed keywords

BIOLOGICAL MARKER;

ANGIOGENESIS; CARDIOVASCULAR RISK; COLLATERAL CIRCULATION; CORONARY ARTERY DISEASE; DIABETES MELLITUS; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; LETTER; MONOCYTE; PRIORITY JOURNAL; SMOKING;

COLLATERAL CIRCULATION; CORONARY VESSELS; HUMANS; LEUKOCYTE COUNT; MONOCYTES;

EID: 38049090018     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2007.10.023     Document Type: Letter

References (12)

1. Kocaman SA, Arslan U, Tavil Y, Okuyan H, Abaci A, Cengel A., Increased circulating monocyte count is related to good collateral development in coronary artery disease. Atherosclerosis 2007, doi:10.1016/j.atherosclerosis.2007.07.010. [Epub ahead of print].
2. Arras M., Ito W.D., Scholz D., Winkler B., Schaper J., and Schaper W. Monocyte activation in angiogenesis and collateral growth in the rabbit hindlimb. J Clin Invest 101 (1998) 40-50
3. Waltenberger J., Lange J., and Kranz A. Vascular endothelial growth factor-A-induced chemotaxis of monocytes is attenuated in patients with diabetes mellitus: a potential predictor for the individual capacity to develop collaterals. Circulation 102 (2000) 185-190
4. Czepluch F.S., Bergler A., and Waltenberger J. Hypercholesterolaemia impairs monocyte function in CAD patients. J Intern Med 261 (2007) 201-204
5. Stadler N., Eggermann J., Voo S., Kranz A., and Waltenberger J. Smoking-induced monocyte dysfunction is reversed by vitamin C supplementation in vivo. Arterioscler Thromb Vasc Biol 27 (2007) 120-126
6. Tirziu D., Moodie K.L., Zhuang Z.W., et al. Delayed arteriogenesis in hypercholesterolemic mice. Circulation 112 (2005) 2501-2509
7. Abaci A., Oguzhan A., Kahraman S., et al. Effect of diabetes mellitus on formation of coronary collateral vessels. Circulation 99 (1999) 2239-2242
8. Werner G.S., Richartz B.M., Heinke S., Ferrari M., and Figulla H.R. Impaired acute collateral recruitment as a possible mechanism for increased cardiac adverse events in patients with diabetes mellitus. Eur Heart J 24 (2003) 1134-1142
9. Olivares R., Ducimetière P., and Claude J.R. Monocyte count: a risk factor for coronary heart disease?. Am J Epidemiol 137 (1993) 49-53
10. Sweetnam P.M., Thomas H.F., Yarnell J.W., Baker I.A., and Elwood P.C. Total and differential leukocyte counts as predictors of ischemic heart disease: the Caerphilly and Speedwell studies. Am J Epidemiol 145 (1997) 416-421
11. Shim W.S., Kim H.J., Kang E.S., et al. The association of total and differential white blood cell count with metabolic syndrome in type 2 diabetic patients. Diabetes Res Clin Pract 73 (2006) 284-291
12. Tsai J.C., Sheu S.H., Chiu H.C., et al. Association of peripheral total and differential leukocyte counts with metabolic syndrome and risk of ischemic cardiovascular diseases in patients with type 2 diabetes mellitus. Diabetes Metab Res Rev 23 (2007) 111-118